- Home
- KTTA vs KXIN Comparison
KTTA vs KXIN Comparison
Compare KTTA & KXIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KTTA
- KXIN
- Stock Information
- Founded
- KTTA 2020
- KXIN 2015
- Country
- KTTA United States
- KXIN China
- Employees
- KTTA 8
- KXIN N/A
- Industry
- KTTA Biotechnology: Pharmaceutical Preparations
- KXIN Retail-Auto Dealers and Gas Stations
- Sector
- KTTA Health Care
- KXIN Consumer Discretionary
- Exchange
- KTTA Nasdaq
- KXIN Nasdaq
- Market Cap
- KTTA 3.4M
- KXIN 3.1M
- IPO Year
- KTTA 2021
- KXIN N/A
- Fundamental
- Price
- KTTA $2.64
- KXIN $1.81
- Analyst Decision
- KTTA
- KXIN
- Analyst Count
- KTTA 0
- KXIN 0
- Target Price
- KTTA N/A
- KXIN N/A
- AVG Volume (30 Days)
- KTTA 57.9K
- KXIN 781.5K
- Earning Date
- KTTA 11-13-2024
- KXIN 01-01-0001
- Dividend Yield
- KTTA N/A
- KXIN N/A
- EPS Growth
- KTTA N/A
- KXIN N/A
- EPS
- KTTA N/A
- KXIN N/A
- Revenue
- KTTA N/A
- KXIN $12,679,000.00
- Revenue This Year
- KTTA N/A
- KXIN N/A
- Revenue Next Year
- KTTA N/A
- KXIN N/A
- P/E Ratio
- KTTA N/A
- KXIN N/A
- Revenue Growth
- KTTA N/A
- KXIN N/A
- 52 Week Low
- KTTA $2.57
- KXIN $1.66
- 52 Week High
- KTTA $9.40
- KXIN $64.80
- Technical
- Relative Strength Index (RSI)
- KTTA 34.15
- KXIN 37.34
- Support Level
- KTTA $2.57
- KXIN $1.66
- Resistance Level
- KTTA $3.07
- KXIN $1.96
- Average True Range (ATR)
- KTTA 0.21
- KXIN 0.14
- MACD
- KTTA 0.01
- KXIN 0.18
- Stochastic Oscillator
- KTTA 14.49
- KXIN 35.46
About KTTA Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia.
About KXIN Kaixin Auto Holdings
Kaixin Holdings is an auto retail platform for luxury used cars and imported new cars. The company is actively engaged in the research and development, design, manufacturing, and sales of electric vehicles and promotes the innovation of next-generation autonomous driving and artificial intelligence technologies. The company primarily generates revenues from sales of used cars, as well as fees obtained from its role as a channel partner for third-party auto financing and other value-added service providers.